189 related articles for article (PubMed ID: 32010572)
1. Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases.
Lohinai Z; Megyesfalvi Z; Suda K; Harko T; Ren S; Moldvay J; Laszlo V; Rivard C; Dome B; Hirsch FR
Transl Lung Cancer Res; 2019 Dec; 8(6):938-950. PubMed ID: 32010572
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
Dora D; Rivard C; Yu H; Bunn P; Suda K; Ren S; Lueke Pickard S; Laszlo V; Harko T; Megyesfalvi Z; Moldvay J; Hirsch FR; Dome B; Lohinai Z
Mol Oncol; 2020 Sep; 14(9):1947-1965. PubMed ID: 32506804
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of molecular subtyping and therapy-related marker expression in primary tumors and paired lymph node metastases of small cell lung cancer.
Zhu Y; Ren W; Li S; Wu J; Hu X; Wang H; Chi K; Zhuo M; Lin D
Virchows Arch; 2024 Feb; ():. PubMed ID: 38347268
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer.
Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Dinya E; Gerdan C; Szegvari G; Hirsch FR; Dome B; Lohinai Z
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34200100
[TBL] [Abstract][Full Text] [Related]
5. Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.
Zhang W; Girard L; Zhang YA; Haruki T; Papari-Zareei M; Stastny V; Ghayee HK; Pacak K; Oliver TG; Minna JD; Gazdar AF
Transl Lung Cancer Res; 2018 Feb; 7(1):32-49. PubMed ID: 29535911
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma.
Handa T; Hayashi T; Ura A; Watanabe I; Takamochi K; Onagi H; Kishi M; Matsumoto N; Tajima K; Kishikawa S; Saito T; Takahashi K; Suzuki K; Yao T
Histopathology; 2023 May; 82(6):860-869. PubMed ID: 36715573
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer.
Wei J; Liu L; Guo Y; Zhang J; Wang X; Dong J; Xing P; Ying J; Yang L; Li J
Thorac Cancer; 2021 Jan; 12(1):40-47. PubMed ID: 33191657
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.
Zhang P; Li Z; Li J; Li J; Zhang X; Lu Z; Sun Y; Li Y; Zhou J; Wang X; Peng Z; Shen L; Lu M
Cancer Med; 2021 Jul; 10(14):4855-4863. PubMed ID: 34109756
[TBL] [Abstract][Full Text] [Related]
9. Involvement of Epithelial-Mesenchymal Transition Genes in Small Cell Lung Cancer Phenotypic Plasticity.
Groves SM; Panchy N; Tyson DR; Harris LA; Quaranta V; Hong T
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900269
[TBL] [Abstract][Full Text] [Related]
10. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.
Cai L; Liu H; Huang F; Fujimoto J; Girard L; Chen J; Li Y; Zhang YA; Deb D; Stastny V; Pozo K; Kuo CS; Jia G; Yang C; Zou W; Alomar A; Huffman K; Papari-Zareei M; Yang L; Drapkin B; Akbay EA; Shames DS; Wistuba II; Wang T; Johnson JE; Xiao G; DeBerardinis RJ; Minna JD; Xie Y; Gazdar AF
Commun Biol; 2021 Mar; 4(1):314. PubMed ID: 33750914
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.
Lissa D; Takahashi N; Desai P; Manukyan I; Schultz CW; Rajapakse V; Velez MJ; Mulford D; Roper N; Nichols S; Vilimas R; Sciuto L; Chen Y; Guha U; Rajan A; Atkinson D; El Meskini R; Weaver Ohler Z; Thomas A
Nat Commun; 2022 Apr; 13(1):2023. PubMed ID: 35440132
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic heterogeneity studied by immunohistochemistry and aneuploidy in non-small cell lung cancers.
Pujol JL; Simony J; Laurent JC; Richer G; Mary H; Bousquet J; Godard P; Michel FB
Cancer Res; 1989 May; 49(10):2797-802. PubMed ID: 2540908
[TBL] [Abstract][Full Text] [Related]
13. The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report.
Pearsall SM; Humphrey S; Revill M; Morgan D; Frese KK; Galvin M; Kerr A; Carter M; Priest L; Blackhall F; Simpson KL; Dive C
J Thorac Oncol; 2020 Dec; 15(12):1836-1843. PubMed ID: 32721553
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes.
Cho HJ; Hong SA; Ryu D; Hong SH; Kim TM
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428693
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.
Travis WD; Linnoila RI; Tsokos MG; Hitchcock CL; Cutler GB; Nieman L; Chrousos G; Pass H; Doppman J
Am J Surg Pathol; 1991 Jun; 15(6):529-53. PubMed ID: 1709558
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors.
Zhang J; Deng J; Feng X; Tan Y; Li X; Liu Y; Li M; Qi H; Tang L; Meng Q; Yan H; Qi L
Front Genet; 2022; 13():944167. PubMed ID: 36105102
[No Abstract] [Full Text] [Related]
17. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung.
Gazdar AF; Savage TK; Johnson JE; Berns A; Sage J; Linnoila RI; MacPherson D; McFadden DG; Farago A; Jacks T; Travis WD; Brambilla E
J Thorac Oncol; 2015 Apr; 10(4):553-64. PubMed ID: 25675280
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma.
Cai L; DeBerardinis RJ; Xie Y; Minna JD; Xiao G
Mol Cancer Res; 2023 Aug; 21(8):795-807. PubMed ID: 37255415
[TBL] [Abstract][Full Text] [Related]
19. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes.
Bebber CM; Thomas ES; Stroh J; Chen Z; Androulidaki A; Schmitt A; Höhne MN; Stüker L; de Pádua Alves C; Khonsari A; Dammert MA; Parmaksiz F; Tumbrink HL; Beleggia F; Sos ML; Riemer J; George J; Brodesser S; Thomas RK; Reinhardt HC; von Karstedt S
Nat Commun; 2021 Apr; 12(1):2048. PubMed ID: 33824345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
